- World rank, 2022–2025
- #23,416 of 28,054 · #32,648 all time
- Rank in United States
- #3,511 of 4,192
- Research works
- 163 ▲ 172% vs 2013–17
- Citations
- 1.7k 10.6 per fractional work
- Top-10% rate
- 9.8% record average 16.5%
- Open access
- 40% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Economics, Econometrics and Finance, 8.2×. Every wedge is a field page.
- Economics, Econometrics and Finance 8.2×
- Decision Sciences 4.2×
- Nursing 2.7×
- Immunology and Microbiology 2.7×
- Neuroscience 2.5×
- Biochemistry, Genetics and Molecular Biology 1.7×
- Medicine 1.7×
- Dentistry 1.4×
- Computer Science 1.4×
- Health Professions 1.1×
- Business, Management and Accounting 0.9×
- Mathematics 0.8×
- Pharmacology, Toxicology and Pharmaceutics 0.7×
- Chemistry 0.6×
- Social Sciences 0.4×
- Psychology 0.3×
- Arts and Humanities 0.3×
- Physics and Astronomy 0.2×
- Agricultural and Biological Sciences 0.2×
- Engineering 0.1×
- Environmental Science 0.0×
Who are the top researchers at Clarivate (United States)?
Ranked on the composite score, Helen Kitchen lead among researchers whose main affiliation is Clarivate (United States).
- 1 Helen Kitchen United States · #1,519,286 worldwide 7 citations · 24 works
Which keywords describe research at Clarivate (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Quality of Life, Cost-effectiveness Analysis, Health Utility Measures, Pharmaceutical Industry, Innovation, Drug Development Costs, Generic Drugs and Immunotherapy.
- Virtual Screening
- Inflammatory Bowel Disease
- Financial Toxicity
- Biosimilars
- Prognosis
- Autoantibodies
- Radiotherapy
- Drug Development
- Anomaly Detection
- Big Data
- Global Collaboration
- Research Evaluation
- Public Health
- Capacity Building
- Genetics
- Immunotherapy
- Drug Development Costs
- Innovation
- Health Utility Measures
- Epidemiology
- Quality of Life
- Cost-effectiveness Analysis
- Machine Learning
- Pharmaceutical Industry
- Generic Drugs
- Clinical Trials
- Bibliometric Analysis
- Interdisciplinary Research
- Regulatory Challenges
- Stem Cell Regulation
- Health Biotechnology
- Glycemic Control
- Autism Spectrum Disorders
- Insulin Therapy
- Survival Analysis
- Distributed Systems
- Skin Cancer
- Cost of Care
- Immunogenicity
- Molecular Docking
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Quality of Life7▲ 7.0×9 topics
- Epidemiology6▲ 2.2×20 topics
- Cost-effectiveness Analysis5▲ 88×1 topic
- Health Utility Measures5▲ 88×1 topic
- Machine Learning5▲ 2.1×14 topics
- Innovation4▲ 5.7×5 topics
- Pharmaceutical Industry4▲ 138×2 topics
- Drug Development Costs4▲ 194×1 topic
- Generic Drugs4▲ 194×1 topic
- Immunotherapy4▲ 7.2×6 topics
- Clinical Trials3▲ 6.2×4 topics
- Genetics3▲ 5.9×9 topics
- Bibliometric Analysis2▲ 57×1 topic
- Capacity Building2▲ 53×2 topics
- Interdisciplinary Research2▲ 37×2 topics
- Public Health2▲ 2.1×6 topics
- Regulatory Challenges2▲ 35×1 topic
- Research Evaluation2▲ 134×1 topic
- Stem Cell Regulation2▲ 137×1 topic
- Global Collaboration2▲ 83×1 topic
- Health Biotechnology2▲ 182×1 topic
- Big Data2▲ 3.0×8 topics
- Glycemic Control2▲ 14×4 topics
- Anomaly Detection2▲ 7.2×2 topics
- Autism Spectrum Disorders2▲ 20×2 topics
- Drug Development2▲ 23×2 topics
- Insulin Therapy2▲ 17×3 topics
- Radiotherapy2▲ 5.4×3 topics
- Survival Analysis2▲ 7.5×3 topics
- Autoantibodies1▲ 8.4×4 topics
- Distributed Systems1▲ 12×4 topics
- Prognosis1▲ 5.8×5 topics
- Skin Cancer1▲ 26×2 topics
- Biosimilars1▲ 92×1 topic
- Cost of Care1▲ 61×1 topic
- Financial Toxicity1▲ 61×1 topic
- Immunogenicity1▲ 43×1 topic
- Inflammatory Bowel Disease1▲ 15×2 topics
- Molecular Docking1▲ 14×1 topic
- Virtual Screening1▲ 20×1 topic
Which research topics does Clarivate (United States) publish most on?
By volume in 2022–2025: Health Systems, Economic Evaluations, Quality of Life, Pharmaceutical Economics and Policy, scientometrics and bibliometrics research and Biomedical Ethics and Regulation.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 5 works
- 2 Pharmaceutical Economics and Policy Economics and Econometrics 4 works
- 3 scientometrics and bibliometrics research Statistics, Probability and Uncertainty 2 works
- 4 Biomedical Ethics and Regulation Physiology 2 works
- 5 Biotechnology and Related Fields Public Health, Environmental and Occupational Health 2 works
- 6 Biosimilars and Bioanalytical Methods Immunology 1 works
- 7 Economic and Financial Impacts of Cancer Economics and Econometrics 1 works
- 8 Computational Drug Discovery Methods Computational Theory and Mathematics 1 works
- 9 Cutaneous Melanoma Detection and Management Oncology 1 works
- 10 Science, Research, and Medicine Reproductive Medicine 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Clarivate (United States)'s research output changed?
Output in 2018–2022 was 172% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Philadelphia
- University of Pennsylvania
- Temple University
- Drexel University
- Thomas Jefferson University
- Children's Hospital of Philadelphia
- Philadelphia University
- Hospital of the University of Pennsylvania
- Fox Chase Cancer Center
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.